Consolidated Statement Of Cash Flows

Nxera Pharma Co., Ltd. - Filing #7272710

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
-4,838,000,000 JPY
-4,838,000,000 JPY
JPY
JPY
-4,838,000,000 JPY
JPY
-7,193,000,000 JPY
-7,193,000,000 JPY
JPY
JPY
-7,193,000,000 JPY
JPY
JPY
Depreciation and amortization
3,984,000,000 JPY
2,478,000,000 JPY
Decrease (increase) in inventories
-5,935,000,000 JPY
1,908,000,000 JPY
Other
-954,000,000 JPY
-527,000,000 JPY
Subtotal
-8,448,000,000 JPY
-4,752,000,000 JPY
Interest paid
-435,000,000 JPY
-241,000,000 JPY
Income taxes paid
-428,000,000 JPY
-1,394,000,000 JPY
Net cash provided by (used in) operating activities
-7,718,000,000 JPY
-5,273,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-526,000,000 JPY
-804,000,000 JPY
Purchase of intangible assets
-1,011,000,000 JPY
-47,000,000 JPY
Payments for acquisition of subsidiaries
JPY
-62,941,000,000 JPY
Other
265,000,000 JPY
1,000,000 JPY
Net cash provided by (used in) investing activities
-4,763,000,000 JPY
-63,791,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
39,900,000,000 JPY
Repayments of long-term borrowings
-5,800,000,000 JPY
-1,450,000,000 JPY
Proceeds from issuance of bonds
JPY
31,708,000,000 JPY
Proceeds from issuance of shares
JPY
9,983,000,000 JPY
Other
-2,000,000 JPY
-27,000,000 JPY
Net cash provided by (used in) financing activities
-6,854,000,000 JPY
48,329,000,000 JPY
Cash and cash equivalents
32,268,000,000 JPY
49,065,000,000 JPY
66,557,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
2,538,000,000 JPY
3,243,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.